UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression

Scientific reports, 2017-07, Vol.7 (1), p.6897-9, Article 6897

2017

Link zum Volltext

Verfügbarkeit prüfen

Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells

Haematologica (Roma), 2011-09, Vol.96 (9), p.1357-1365

2011

Link zum Volltext

Verfügbarkeit prüfen

Rapamycin and Interleukin-10 Treatment Induces T Regulatory Type 1 Cells That Mediate Antigen-Specific Transplantation Tolerance

Diabetes (New York, N.Y.), 2006-01, Vol.55 (1), p.40-49

2006

Link zum Volltext

Verfügbarkeit prüfen

Altered Frequency and Phenotype of HLA-G-Expressing DC-10 in Type 1 Diabetes Patients at Onset and in Subjects at Risk to Develop the Disease

Frontiers in immunology, 2021-10, Vol.12, p.750162-750162

2021

Link zum Volltext

Verfügbarkeit prüfen

Induction of Tolerance in Type 1 Diabetes via Both CD4+CD25+ T Regulatory Cells and T Regulatory Type 1 Cells

Diabetes (New York, N.Y.), 2006-06, Vol.55 (6), p.1571-1580

2006

Link zum Volltext

Verfügbarkeit prüfen

Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet Transplant

Diabetes (New York, N.Y.), 2010-02, Vol.59 (2), p.433-439

2010

Link zum Volltext

Verfügbarkeit prüfen

Impaired exocrine pancreatic function in different stages of type 1 diabetes

BMJ open diabetes research & care, 2021-02, Vol.9 (1), p.e001158

2021

Link zum Volltext

Verfügbarkeit prüfen

Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation

PloS one, 2011-12, Vol.6 (12), p.e28434-e28434

2011

Link zum Volltext

Verfügbarkeit prüfen

Rapamycin Prevents and Breaks the Anti-CD3–Induced Tolerance in NOD Mice

Diabetes (New York, N.Y.), 2009-04, Vol.58 (4), p.875-881

2009

Link zum Volltext

Verfügbarkeit prüfen

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells

Blood, 2005-06, Vol.105 (12), p.4743-4748

2005

Link zum Volltext

Verfügbarkeit prüfen

Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients

The Journal of immunology (1950), 2006-12, Vol.177 (12), p.8338-8347

2006

Link zum Volltext

Verfügbarkeit prüfen

Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes

Diabetes (New York, N.Y.), 2011-11, Vol.60 (11), p.2903-2913

2011

Link zum Volltext

Verfügbarkeit prüfen

Generation of donor-specific Tr1 cells to be used after kidney transplantation and definition of the timing of their in vivo infusion in the presence of immunosuppression

Journal of translational medicine, 2017-02, Vol.15 (1), p.40-40, Article 40

2017

Link zum Volltext

Verfügbarkeit prüfen

Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes

Diabetes (New York, N.Y.), 2013-06, Vol.62 (6), p.2072-2077

2013

Link zum Volltext

Verfügbarkeit prüfen

Autoantibody binding in liquid phase to IL-2 in human sera is not type 1 diabetes specific

Diabetologia, 2017-09, Vol.60 (9), p.1834-1835

2017

Link zum Volltext

Verfügbarkeit prüfen

Reduced PD-1 expression on circulating follicular and conventional FOXP3+ Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children

Clinical immunology (Orlando, Fla.), 2020-02, Vol.211, p.108319-108319, Article 108319

2020

Link zum Volltext

Verfügbarkeit prüfen

Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation

The Journal of immunology (1950), 2015-03, Vol.194 (5), p.2117-2127

2015

Link zum Volltext

Verfügbarkeit prüfen

Lack of the protein tyrosine phosphatase PTPN22 strengthens transplant tolerance to pancreatic islets in mice

Diabetologia, 2015-06, Vol.58 (6), p.1319-1328

2015

Link zum Volltext

Verfügbarkeit prüfen

Exocrine pancreas function is impaired in adult relatives of patients with type 1 diabetes

Acta diabetologica, 2022-04, Vol.59 (4), p.473-479

2022

Link zum Volltext

Verfügbarkeit prüfen

Expanding human T regulatory cells with the mTOR-inhibitor rapamycin

Methods in molecular biology (Clifton, N.J.), 2012, Vol.821, p.279

2012

Link zum Volltext

Verfügbarkeit prüfen

Expansion of Thl7 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 Diabetes

Diabetes (New York, N.Y.), 2011, Vol.60 (11), p.2303-2313

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)
Buchkapitel
(1)

Sprache

Englisch
(30)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(23)
Humans
(14)
Animals
(12)
Endocrinology & Metabolism
(12)
Female
(11)
Mice
(11)
Type 1 Diabetes
(11)
Biological And Medical Sciences
(9)
Diabetes Mellitus, Type 1 - Immunology
(8)
Medical Sciences
(8)
Sirolimus - Pharmacology
(8)
Adult
(6)
Autoantibodies
(6)
Diabetes
(6)
Diabetes Mellitus
(6)
Diabetes. Impaired Glucose Tolerance
(6)
Endocrine Pancreas. Apud Cells
(6)
Endocrinopathies
(6)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression

Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells

Rapamycin and Interleukin-10 Treatment Induces T Regulatory Type 1 Cells That Mediate Antigen-Specific Transplantation Tolerance

Altered Frequency and Phenotype of HLA-G-Expressing DC-10 in Type 1 Diabetes Patients at Onset and in Subjects at Risk to Develop the Disease

Combined unsupervised and semi-automated supervised analysis of flow cytometry data reveals cellular fingerprint associated with newly diagnosed pediatric type 1 diabetes

Induction of Tolerance in Type 1 Diabetes via Both CD4+CD25+ T Regulatory Cells and T Regulatory Type 1 Cells

Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet Transplant

Impaired exocrine pancreatic function in different stages of type 1 diabetes

Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation

Rapamycin Prevents and Breaks the Anti-CD3–Induced Tolerance in NOD Mice

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells

Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients

Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes

Generation of donor-specific Tr1 cells to be used after kidney transplantation and definition of the timing of their in vivo infusion in the presence of immunosuppression

Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes

Reduced Follicular Regulatory T Cells in Spleen and Pancreatic Lymph Nodes of Patients With Type 1 Diabetes

Autoantibody binding in liquid phase to IL-2 in human sera is not type 1 diabetes specific

Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset

Reduced PD-1 expression on circulating follicular and conventional FOXP3+ Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children

Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation

Lack of the protein tyrosine phosphatase PTPN22 strengthens transplant tolerance to pancreatic islets in mice

Exocrine pancreas function is impaired in adult relatives of patients with type 1 diabetes

Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes

Expanding human T regulatory cells with the mTOR-inhibitor rapamycin

Expansion of Thl7 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 Diabetes

Suchergebnisse filtern